CA2989491C - Systeme cellulaire d'administration ciblee de principe actif - Google Patents

Systeme cellulaire d'administration ciblee de principe actif

Info

Publication number
CA2989491C
CA2989491C CA2989491A CA2989491A CA2989491C CA 2989491 C CA2989491 C CA 2989491C CA 2989491 A CA2989491 A CA 2989491A CA 2989491 A CA2989491 A CA 2989491A CA 2989491 C CA2989491 C CA 2989491C
Authority
CA
Canada
Prior art keywords
amino acid
delivery system
targeted delivery
monocyte
macrophage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2989491A
Other languages
English (en)
Other versions
CA2989491A1 (fr
Inventor
Magdalena KROL
Irene BENNI
Paola BAIOCCO
Tomasz RYGIEL
Alberto Boffi
Original Assignee
Cellis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL412787A external-priority patent/PL412787A1/pl
Application filed by Cellis AG filed Critical Cellis AG
Publication of CA2989491A1 publication Critical patent/CA2989491A1/fr
Application granted granted Critical
Publication of CA2989491C publication Critical patent/CA2989491C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne un système cellulaire isolé d'administration ciblée comportant une cellule leucocytaire CD45+ et, à l'intérieur de cette cellule, un complexe associant une ou plusieurs protéines de liaison au fer et un principe actif, ainsi que des procédés de production d'un tel système cellulaire isolé d'administration ciblée et les utilisations d'un tel système pour une thérapie, en particulier pour une thérapie anticancéreuse.
CA2989491A 2015-06-22 2016-06-22 Systeme cellulaire d'administration ciblee de principe actif Active CA2989491C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL412787 2015-06-22
PL412787A PL412787A1 (pl) 2015-06-22 2015-06-22 Oparty na makrofagach celowany system dostarczania związków związanych z ferrytyną
PCT/EP2016/064484 WO2016207257A1 (fr) 2015-06-22 2016-06-22 Système cellulaire d'administration ciblée de principe actif

Publications (2)

Publication Number Publication Date
CA2989491A1 CA2989491A1 (fr) 2016-12-29
CA2989491C true CA2989491C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
AU2016282846B2 (en) Cellular targeted active ingredient delivery system
EP3475415A1 (fr) Système de distribution d'étiquettes ou de substances pharmaceutiquement actives à ciblage cellulaire
US20250075182A1 (en) Cellular targeted active ingredient delivery system
CA2989491C (fr) Systeme cellulaire d'administration ciblee de principe actif
HK1253919B (en) Cellular targeted active ingredient delivery system
US20260091119A1 (en) Isolated targeted delivery system for the treatment of glioma
BR112017027876B1 (pt) Sistema de distribuição, método de preparação do sistema e composição farmacêutica
WO2024133541A1 (fr) Système isolé d'administration ciblée pour le traitement du cancer de l'ovaire
EP3650046A1 (fr) Système d'administration d'ingrédients actifs ciblés à base de cellules souches mésenchymateuses
HK1253922A1 (en) Cellular targeted label delivery system